Saroja Pharma Industries India Limited (NSE: SAROJA)
India
· Delayed Price · Currency is INR 58.20
0.00 (0.00%)
At close: Oct 1, 2024
SAROJA Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Operating Revenue | 406.69 | 406.69 | 501.93 | 556.33 | 366.62 | 170.8 |
| Other Revenue | - | - | - | - | 0 | - |
| Revenue | 406.69 | 406.69 | 501.93 | 556.33 | 366.62 | 170.8 |
| Revenue Growth (YoY) | -18.97% | -18.97% | -9.78% | 51.75% | 114.65% | - |
| Cost of Revenue | 356.41 | 356.41 | 452.96 | 503.52 | 333.41 | 153.8 |
| Gross Profit | 50.28 | 50.28 | 48.97 | 52.8 | 33.2 | 17 |
| Selling, General & Admin | 14.63 | 14.63 | 15.57 | 13.36 | 10.08 | 7.52 |
| Other Operating Expenses | 10.12 | 10.12 | 5.59 | 16.85 | 9.38 | 5.67 |
| Operating Expenses | 25.69 | 25.69 | 21.83 | 30.66 | 19.69 | 13.23 |
| Operating Income | 24.6 | 24.6 | 27.14 | 22.14 | 13.52 | 3.77 |
| Interest Expense | -14.46 | -14.46 | -9.95 | -6.66 | -2.65 | -1.46 |
| Interest & Investment Income | - | - | 0.13 | 0.1 | 0.04 | 0.01 |
| Currency Exchange Gain (Loss) | - | - | 0.84 | 1.58 | 0.12 | 0.05 |
| Other Non Operating Income (Expenses) | 1.93 | 1.93 | -3.25 | -1.36 | -0.67 | -0.14 |
| EBT Excluding Unusual Items | 12.07 | 12.07 | 14.92 | 15.79 | 10.35 | 2.24 |
| Legal Settlements | - | - | - | - | - | -0.09 |
| Pretax Income | 12.07 | 12.07 | 14.92 | 15.79 | 10.35 | 2.15 |
| Income Tax Expense | 3.29 | 3.29 | 4.31 | 4.39 | 3.04 | 0.54 |
| Net Income | 8.78 | 8.78 | 10.61 | 11.4 | 7.31 | 1.61 |
| Net Income to Common | 8.78 | 8.78 | 10.61 | 11.4 | 7.31 | 1.61 |
| Net Income Growth | -17.19% | -17.19% | -6.97% | 55.90% | 354.42% | - |
| Shares Outstanding (Basic) | 4 | 4 | 3 | 3 | 3 | 0 |
| Shares Outstanding (Diluted) | 4 | 4 | 3 | 3 | 3 | 0 |
| Shares Change (YoY) | 20.15% | 20.15% | 2.08% | 5.73% | 1992.20% | - |
| EPS (Basic) | 2.49 | 2.49 | 3.61 | 3.96 | 2.69 | 12.38 |
| EPS (Diluted) | 2.49 | 2.49 | 3.61 | 3.96 | 2.69 | 12.38 |
| EPS Growth | -31.02% | -31.02% | -8.84% | 47.28% | -78.28% | - |
| Free Cash Flow | -37.04 | -37.04 | -15.34 | -39.76 | -11.01 | -9.09 |
| Free Cash Flow Per Share | -10.50 | -10.50 | -5.22 | -13.83 | -4.05 | -69.93 |
| Gross Margin | 12.36% | 12.36% | 9.76% | 9.49% | 9.06% | 9.95% |
| Operating Margin | 6.05% | 6.05% | 5.41% | 3.98% | 3.69% | 2.21% |
| Profit Margin | 2.16% | 2.16% | 2.11% | 2.05% | 1.99% | 0.94% |
| Free Cash Flow Margin | -9.11% | -9.11% | -3.06% | -7.15% | -3.00% | -5.32% |
| EBITDA | 25.54 | 25.54 | 27.8 | 22.56 | 13.72 | 3.82 |
| EBITDA Margin | 6.28% | 6.28% | 5.54% | 4.05% | 3.74% | 2.23% |
| D&A For EBITDA | 0.95 | 0.95 | 0.65 | 0.42 | 0.21 | 0.05 |
| EBIT | 24.6 | 24.6 | 27.14 | 22.14 | 13.52 | 3.77 |
| EBIT Margin | 6.05% | 6.05% | 5.41% | 3.98% | 3.69% | 2.21% |
| Effective Tax Rate | 27.24% | 27.24% | 28.89% | 27.81% | 29.37% | 25.18% |
| Revenue as Reported | 408.63 | 408.63 | 503.51 | 559.57 | 367.47 | 170.86 |
| Advertising Expenses | - | - | 1.14 | 1.2 | 1.03 | 1.08 |
Source: S&P Capital IQ. Standard template. Financial Sources.